Retractable Technologies Inc

$ 0.67

-1.03%

07 Aug - close price

  • Market Cap 20,057,900 USD
  • Current Price $ 0.67
  • High / Low $ 0.68 / 0.67
  • Stock P/E N/A
  • Book Value 2.33
  • EPS -0.22
  • Next Earning Report 2026-08-13
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.09 %
  • ROE -0.09 %
  • 52 Week High 1.14
  • 52 Week Low 0.60

About

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, the rest of North and South America, and internationally. The company is headquartered in Little Elm, Texas.

Analyst Target Price

N/A

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-152026-03-272025-11-142025-08-142025-05-152025-03-282024-11-142024-08-142024-05-152024-03-292023-11-142023-08-14
Reported EPS -0.1431-0.08040.01-0.0048-0.110.124-0.0661-0.47510.0124-0.0044-0.1376-0.1302
Estimated EPS NoneNoneNone0NoneNoneNoneNoneNoneNoneNoneNone
Surprise 000-0.004800000000
Surprise Percentage None%None%None%None%None%None%None%None%None%None%None%None%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-13
Fiscal Date Ending 2026-06-30
Estimated EPS
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: RVP

...
Retractable Technologies Inc (RVP) Stock News Today

2026-08-08 08:39:58

This article provides a brief update on Retractable Technologies Inc (RVP) stock, noting its current trading price and market cap. It indicates that more news regarding earnings, analyst ratings, and key developments will be available soon. The page serves as a placeholder for future stock-related news for RVP.

...
Retractable Technologies Inc (RVP) Earnings Forecast: Future EPS & Revenue Growth Estimates

2026-08-08 05:11:05

This article provides an earnings forecast for Retractable Technologies Inc (RVP), detailing future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a comparison with peers in the healthcare equipment and supplies sector. The content appears to be a stub or a section of a larger financial analysis platform.

...
Retractable Technologies Inc (RVP) Risk Assessment: Volatility, Financial Risk & Investment Risk

2026-07-31 17:10:38

This article provides a risk assessment for Retractable Technologies Inc (RVP), detailing its volatility, financial risk, and investment risk. RVP has a risk assessment score of 2.69, ranking 143 out of 200 in the Healthcare Equipment & Supplies industry. Key metrics like beta, maximum drawdown, volatility, and liquidity are presented, indicating the stock's performance characteristics relative to the S&P 500.

...
ETFs Investing in Retractable Technologies, Inc. Stocks

2026-07-31 05:39:25

This article lists ETFs that hold Retractable Technologies, Inc. (RVP) stocks, sorted by market value. It highlights the BUSM EA Bridgeway Ultra-Small Company Market ETF as one such fund, providing details on its market value, weight, issuer, management style, expense ratio, and AUM. The information aims to make investing in stocks more accessible and offer diversified opportunities with lower risk through ETFs.

...
ETFs Investing in Retractable Technologies, Inc. Stocks

2026-07-30 19:09:51

This article lists ETFs that invest in Retractable Technologies, Inc. (RVP) stocks, providing details such as market value, weight, issuer, and expense ratio for each fund. It aims to help investors find opportunities with lower risk through diversified ETF holdings. The only listed ETF is the Bridgeway Ultra-Small Company Market ETF (BUSM EA).

...
Retractable Technologies Inc (RVP) Financial Health: Profitability & Balance Sheet Analysis

2026-07-29 03:10:01

Retractable Technologies Inc (RVP) has a weak financial status with an average operating efficiency, ranking 172 out of 199 in its industry. The company reported a 13.48% year-over-year decrease in quarterly revenue and a 59.44% decrease in net profit. Various financial health dimensions like Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns indicate that relevant data has not been fully disclosed by the company, making a comprehensive analysis difficult.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi